Recruiting
Phase 2
Lymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC · started 2025-04-11
📍 Alabama · Arizona · Arkansas · California · Colorado · Delaware · District of Columbia · Florida
NCT06890884 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC · started 2025-05-13
📍 Arizona · California · Colorado · Connecticut · District of Columbia · Florida · Georgia · Illinois
NCT06925737 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Growth Hormone Deficiency (GHD)
Lumos Pharma · started 2026-05-20
📍 Alabama · California · Colorado · District of Columbia · Florida · Indiana · Iowa · Louisiana
NCT06948214 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx · started 2025-09-16
📍 Alabama · California · Colorado · District of Columbia · Florida · Louisiana · Pennsylvania · Texas
NCT07091630 on ClinicalTrials.gov ↗
Active
Phase 2
Overweight, Type 2 Diabetes, Obesity
Zealand Pharma · started 2025-04-22
📍 Alabama · Arizona · Arkansas · California · Connecticut · District of Columbia · Florida · Georgia
NCT06926842 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM, Glioblastoma Multiforme (GBM)
Black Diamond Therapeutics, Inc. · started 2026-05-05
📍 Alabama · Arkansas · California · Connecticut · District of Columbia · Florida · Maryland · Massachusetts
NCT07326566 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Chronic Migraine in Children
H. Lundbeck A/S · started 2021-06-30
📍 Connecticut · District of Columbia · Florida · Georgia · Kentucky · Maryland · Michigan · New York
NCT04965675 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Early Breast Cancer
Novartis Pharmaceuticals · started 2024-02-28
📍 Alabama · Alaska · Arizona · Arkansas · California · Colorado · District of Columbia · Florida
NCT05827081 on ClinicalTrials.gov ↗
By invitation
Phase 3
Systemic Lupus Erythematosus (SLE)
Biogen · started 2022-06-10
📍 Arizona · California · Colorado · District of Columbia · Florida · Georgia · Massachusetts · Michigan
NCT05352919 on ClinicalTrials.gov ↗
Recruiting
Phase 2/Phase 3
Heart Failure, Left Ventricular Systolic Dysfunction
Merck Sharp & Dohme LLC · started 2023-05-31
📍 California · Colorado · District of Columbia · Florida · Georgia · Massachusetts · Michigan · Missouri
NCT05714085 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC · started 2021-05-12
📍 Arizona · California · Colorado · District of Columbia · Florida · Kansas · Kentucky · Maryland
NCT07218029 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company · started 2025-12-12
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT07218380 on ClinicalTrials.gov ↗
Recruiting
Phase 2/Phase 3
Heterozygous Familial Hypercholesterolemia (HeFH)
Merck Sharp & Dohme LLC · started 2025-08-21
📍 Delaware · District of Columbia · Florida · Georgia · Massachusetts · Ohio · West Virginia
NCT07058077 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Migraine
AbbVie · started 2022-01-13
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT05125302 on ClinicalTrials.gov ↗
Active
Phase 4
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
Novartis Pharmaceuticals · started 2019-11-04
📍 Arizona · District of Columbia · Florida · Indiana · Maryland · Massachusetts · Minnesota · New York
NCT03975829 on ClinicalTrials.gov ↗
Active
Phase 3
HIV Infections
ViiV Healthcare · started 2015-02-23
📍 California · Colorado · Connecticut · District of Columbia · Florida · Georgia · Illinois · Indiana
NCT02362503 on ClinicalTrials.gov ↗
No trials match your search.